UK markets closed

Teva Pharmaceutical Industries Limited (TEVA.TA)

Tel Aviv - Tel Aviv Delayed price. Currency in ILA (0.01 ILS)
Add to watchlist
5,156.00-18.00 (-0.35%)
As of 02:17PM IDT. Market open.
Currency in ILA

Valuation measures4

Market cap (intra-day) 58.60B
Enterprise value 122.20B
Trailing P/E 921.38
Forward P/E 5.82
PEG ratio (5-yr expected) N/A
Price/sales (ttm)0.98
Price/book (mrq)2.09
Enterprise value/revenue 7.71
Enterprise value/EBITDA 78.43

Trading information

Stock price history

Beta (5Y monthly) 1.06
52-week change 361.49%
S&P500 52-week change 322.38%
52-week high 35,379.00
52-week low 32,637.00
50-day moving average 34,984.58
200-day moving average 34,094.75

Share statistics

Avg vol (3-month) 31.4M
Avg vol (10-day) 32.93M
Shares outstanding 51.13B
Implied shares outstanding 61.13B
Float 81.11B
% held by insiders 10.56%
% held by institutions 18.97%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 42.96
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 428 Nov 2017
Last split factor 22:1
Last split date 327 Jun 2004

Financial highlights

Currency in USD.

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin -3.53%
Operating margin (ttm)28.05%

Management effectiveness

Return on assets (ttm)4.54%
Return on equity (ttm)-7.36%

Income statement

Revenue (ttm)15.85B
Revenue per share (ttm)14.16
Quarterly revenue growth (yoy)14.80%
Gross profit (ttm)N/A
EBITDA 4.33B
Net income avi to common (ttm)-559M
Diluted EPS (ttm)-1.87
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)3.23B
Total cash per share (mrq)2.88
Total debt (mrq)20.27B
Total debt/equity (mrq)249.48%
Current ratio (mrq)1.02
Book value per share (mrq)6.70

Cash flow statement

Operating cash flow (ttm)1.37B
Levered free cash flow (ttm)3.29B